Jennifer Hayes-Bethel
Family Medicine · Bowling Green, MONPI 1467650101
Payments from drug & device makers
Across 122 payments — averaging $36.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$2K
- Exact Sciences$335
- Neurocrine Biosciences, Inc.$313
- Merck$258
- Pfizer$192
- Theratechnologies Inc.$171
- plus $799 from 22 others
What the payments were for
- Consulting fees$2,41554%
- Food & beverage$2,05346%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 3 | $2,415 |
| Exact Sciences | 15 | $335 |
| Neurocrine Biosciences, Inc. | 13 | $313 |
| Merck | 12 | $258 |
| Pfizer | 22 | $192 |
| Theratechnologies Inc. | 9 | $171 |
| Johnson & Johnson(2 entities) | 6 | $127 |
| GSK | 4 | $60 |
| Lilly USA, LLC | 4 | $60 |
| Viiv Healthcare Company | 3 | $58 |
| AbbVie(2 entities) | 3 | $49 |
| Mylan Specialty L.p. | 3 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Gilead | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $36 |
| Amarin Pharma, Inc. | 2 | $32 |
| Cranial Technologies, Inc | 2 | $29 |
| Boehringer Ingelheim | 2 | $26 |
| Amgen | 2 | $24 |
| QOL Medical, LLC | 1 | $23 |
| Phadia US Inc. | 1 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Sanofi | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYVASO$1,645
How this compares
$4,483 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $20,246 |
| EliquisApixaban | 13 | $11,653 |
| Gabapentin | 23 | $957 |
| Rosuvastatin Calcium | 24 | $865 |
| Atorvastatin Calcium | 54 | $376 |
| Levothyroxine Sodium | 35 | $318 |
| Lisinopril | 41 | $269 |
| Losartan Potassium | 31 | $253 |
| Propranolol Hcl ErPropranolol Hcl | 11 | $247 |
| Omeprazole | 19 | $195 |
| Metoprolol Succinate | 13 | $186 |
| Pantoprazole Sodium | 12 | $165 |
| Amlodipine Besylate | 42 | $133 |
| Hydrochlorothiazide | 13 | $70 |
| Metformin Hcl | 22 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $192 | $11,65313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Bowling Green
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.